| Dr John W Shaw, MD | |
|
1400 E 2nd St, Defiance, OH 43512-2440 | |
| (419) 784-1414 | |
| Not Available |
| Full Name | Dr John W Shaw |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 34 Years |
| Location | 1400 E 2nd St, Defiance, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104858745 | NPI | - | NPPES |
| 0156370 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 35068596 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Health - Defiance Hospital | Defiance, OH | Hospital |
| Paulding County Hospital | Paulding, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Medical Partners Northern Region Specialty Care Llc | 9739585480 | 79 |
News Archive
The 2012 Health Sciences Research Day and Postgraduate Expo takes place on Wednesday, 19 September 2012 under the theme: Excellence. Relevance. Determination. Transforming Life through Research Excellence.
Genencor International, Inc. today announced that it has agreed to sell its therapeutic vaccine program to Belgian biotechnology company Innogenetics N.V. Innogenetics will develop and commercialize current product candidates in Genencor's vaccine product portfolio as well as future products based on intellectual property and technology held by Genencor.
BioSystem Development, a privately held life science analytics company, announces a recently completed investment round that raised $978,000 (USD) in funding. The proceeds will be used to expand manufacturing infrastructure and to launch new products into the biopharmaceutical development market.
Radiologists and medical imaging business managers will learn strategies to overcome professional challenges in reimbursement, practice sustainability and demonstrating value at the ACR-RBMA Practice Leaders Forum.
The proposed link between caffeine and reductions in the beta amyloid plaque accumulation characteristic of Alzheimer's disease (AD) suggest a possible role for caffeine in AD treatment. The latest evidence linking beta amyloid protein to Alzheimer's disease and exploring the relationship between caffeine and beta amyloid are featured in a review article in Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
› Verified 8 days ago
| Entity Name | Mercy Health Physicians-north Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609000769 PECOS PAC ID: 2668522400 Enrollment ID: O20090616000750 |
News Archive
The 2012 Health Sciences Research Day and Postgraduate Expo takes place on Wednesday, 19 September 2012 under the theme: Excellence. Relevance. Determination. Transforming Life through Research Excellence.
Genencor International, Inc. today announced that it has agreed to sell its therapeutic vaccine program to Belgian biotechnology company Innogenetics N.V. Innogenetics will develop and commercialize current product candidates in Genencor's vaccine product portfolio as well as future products based on intellectual property and technology held by Genencor.
BioSystem Development, a privately held life science analytics company, announces a recently completed investment round that raised $978,000 (USD) in funding. The proceeds will be used to expand manufacturing infrastructure and to launch new products into the biopharmaceutical development market.
Radiologists and medical imaging business managers will learn strategies to overcome professional challenges in reimbursement, practice sustainability and demonstrating value at the ACR-RBMA Practice Leaders Forum.
The proposed link between caffeine and reductions in the beta amyloid plaque accumulation characteristic of Alzheimer's disease (AD) suggest a possible role for caffeine in AD treatment. The latest evidence linking beta amyloid protein to Alzheimer's disease and exploring the relationship between caffeine and beta amyloid are featured in a review article in Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
› Verified 8 days ago
| Entity Name | Mercy Medical Partners Northern Region Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669756532 PECOS PAC ID: 0244407823 Enrollment ID: O20120123000509 |
News Archive
The 2012 Health Sciences Research Day and Postgraduate Expo takes place on Wednesday, 19 September 2012 under the theme: Excellence. Relevance. Determination. Transforming Life through Research Excellence.
Genencor International, Inc. today announced that it has agreed to sell its therapeutic vaccine program to Belgian biotechnology company Innogenetics N.V. Innogenetics will develop and commercialize current product candidates in Genencor's vaccine product portfolio as well as future products based on intellectual property and technology held by Genencor.
BioSystem Development, a privately held life science analytics company, announces a recently completed investment round that raised $978,000 (USD) in funding. The proceeds will be used to expand manufacturing infrastructure and to launch new products into the biopharmaceutical development market.
Radiologists and medical imaging business managers will learn strategies to overcome professional challenges in reimbursement, practice sustainability and demonstrating value at the ACR-RBMA Practice Leaders Forum.
The proposed link between caffeine and reductions in the beta amyloid plaque accumulation characteristic of Alzheimer's disease (AD) suggest a possible role for caffeine in AD treatment. The latest evidence linking beta amyloid protein to Alzheimer's disease and exploring the relationship between caffeine and beta amyloid are featured in a review article in Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
› Verified 8 days ago
| Entity Name | Mercy Health Physicians North Specialty Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306468418 PECOS PAC ID: 1951707884 Enrollment ID: O20210901001534 |
News Archive
The 2012 Health Sciences Research Day and Postgraduate Expo takes place on Wednesday, 19 September 2012 under the theme: Excellence. Relevance. Determination. Transforming Life through Research Excellence.
Genencor International, Inc. today announced that it has agreed to sell its therapeutic vaccine program to Belgian biotechnology company Innogenetics N.V. Innogenetics will develop and commercialize current product candidates in Genencor's vaccine product portfolio as well as future products based on intellectual property and technology held by Genencor.
BioSystem Development, a privately held life science analytics company, announces a recently completed investment round that raised $978,000 (USD) in funding. The proceeds will be used to expand manufacturing infrastructure and to launch new products into the biopharmaceutical development market.
Radiologists and medical imaging business managers will learn strategies to overcome professional challenges in reimbursement, practice sustainability and demonstrating value at the ACR-RBMA Practice Leaders Forum.
The proposed link between caffeine and reductions in the beta amyloid plaque accumulation characteristic of Alzheimer's disease (AD) suggest a possible role for caffeine in AD treatment. The latest evidence linking beta amyloid protein to Alzheimer's disease and exploring the relationship between caffeine and beta amyloid are featured in a review article in Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
› Verified 8 days ago
| Entity Name | Mercy Medical Partners Northern Region Specialty Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730701749 PECOS PAC ID: 9739585480 Enrollment ID: O20210907000836 |
News Archive
The 2012 Health Sciences Research Day and Postgraduate Expo takes place on Wednesday, 19 September 2012 under the theme: Excellence. Relevance. Determination. Transforming Life through Research Excellence.
Genencor International, Inc. today announced that it has agreed to sell its therapeutic vaccine program to Belgian biotechnology company Innogenetics N.V. Innogenetics will develop and commercialize current product candidates in Genencor's vaccine product portfolio as well as future products based on intellectual property and technology held by Genencor.
BioSystem Development, a privately held life science analytics company, announces a recently completed investment round that raised $978,000 (USD) in funding. The proceeds will be used to expand manufacturing infrastructure and to launch new products into the biopharmaceutical development market.
Radiologists and medical imaging business managers will learn strategies to overcome professional challenges in reimbursement, practice sustainability and demonstrating value at the ACR-RBMA Practice Leaders Forum.
The proposed link between caffeine and reductions in the beta amyloid plaque accumulation characteristic of Alzheimer's disease (AD) suggest a possible role for caffeine in AD treatment. The latest evidence linking beta amyloid protein to Alzheimer's disease and exploring the relationship between caffeine and beta amyloid are featured in a review article in Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John W Shaw, MD 1400 E 2nd St, Defiance, OH 43512-2440 Ph: (419) 784-1414 | Dr John W Shaw, MD 1400 E 2nd St, Defiance, OH 43512-2440 Ph: (419) 784-1414 |
News Archive
The 2012 Health Sciences Research Day and Postgraduate Expo takes place on Wednesday, 19 September 2012 under the theme: Excellence. Relevance. Determination. Transforming Life through Research Excellence.
Genencor International, Inc. today announced that it has agreed to sell its therapeutic vaccine program to Belgian biotechnology company Innogenetics N.V. Innogenetics will develop and commercialize current product candidates in Genencor's vaccine product portfolio as well as future products based on intellectual property and technology held by Genencor.
BioSystem Development, a privately held life science analytics company, announces a recently completed investment round that raised $978,000 (USD) in funding. The proceeds will be used to expand manufacturing infrastructure and to launch new products into the biopharmaceutical development market.
Radiologists and medical imaging business managers will learn strategies to overcome professional challenges in reimbursement, practice sustainability and demonstrating value at the ACR-RBMA Practice Leaders Forum.
The proposed link between caffeine and reductions in the beta amyloid plaque accumulation characteristic of Alzheimer's disease (AD) suggest a possible role for caffeine in AD treatment. The latest evidence linking beta amyloid protein to Alzheimer's disease and exploring the relationship between caffeine and beta amyloid are featured in a review article in Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
› Verified 8 days ago
Dr. Souheil Al-jadda, Surgery Medicare: Not Enrolled in Medicare Practice Location: 1400 E 2nd St, Defiance, OH 43512 Phone: 419-784-1414 | |
Dr. Truman Frederick Weigand Jr., MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1250 Ralston Ave Ste 204, Defiance, OH 43512 Phone: 419-783-6997 Fax: 419-782-6103 | |
Jeffrey Robert Walters, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 E 2nd St, Defiance, OH 43512 Phone: 419-784-1414 Fax: 419-784-1414 | |
Joe W Sayre, MD Surgery Medicare: Medicare Enrolled Practice Location: 1250 Ralston Ave, Suite 203, Defiance, OH 43512 Phone: 419-783-6997 Fax: 419-782-6873 | |
Dr. William H. Strawter, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1250 Ralston Ave, Suite 203, Defiance, OH 43512 Phone: 419-783-6997 Fax: 419-782-6103 | |
Dr. Jeffrey A. Pruitt, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 E 2nd St, Defiance, OH 43512 Phone: 419-784-1414 |